RESUMEN
UNLABELLED: Despite adolescent black females experiencing the highest rates of obesity, the effect of excess fat mass on bone structure and strength in this population is unknown. Our findings in postadolescent black females suggest that excess weight in the form of fat mass may adversely influence cortical bone structure and strength. INTRODUCTION: Although adolescent obesity has been associated with reduced bone structure and strength in white females, this relationship has not been studied in adolescent black females, a population experiencing the highest rates of obesity. Our objective was to compare bone structure and strength between postadolescent black females with normal and high levels of adiposity. METHODS: Black females with ≤ 32% body fat were classified as normal body fat (NF; n = 33, aged 19.3 ± 1.3 years); females exceeding this cutoff were classified as high body fat (HF; n = 15, aged 19.0 ± 1.1 years). Using peripheral quantitative computed tomography, tibial and radial bones were scanned at the 4% (trabecular) and 20% (cortical) sites from the distal metaphyses. Fat-free soft-tissue mass (FFST) and %body fat were assessed by dual-energy X-ray absorptiometry. RESULTS: After controlling for either FFST or body weight, the HF vs. NF group had lower total cross-sectional area (CSA; 9-17%), cortical CSA (6-15%), and strength-strain index (SSI; 13-24%) at the cortical site of the tibia (all p < 0.05). At the cortical site of the radius, the HF vs. NF group had lower total CSA (14%, p = 0.03), cortical CSA (9%, p = 0.04), and SSI (15%, p = 0.07) after control for body weight. There were no group differences in either the FFST-adjusted cortical bone values at the radius or in the trabecular bone parameters (body weight- or FFST-adjusted) at the tibia and radius. CONCLUSIONS: Consistent with our adiposity and bone data in late-adolescent white females, our findings in black females entering adulthood also suggest that obesity may adversely influence cortical bone strength.
Asunto(s)
Tejido Adiposo/diagnóstico por imagen , Densidad Ósea/fisiología , Radio (Anatomía)/diagnóstico por imagen , Tibia/diagnóstico por imagen , Absorciometría de Fotón , Adolescente , Negro o Afroamericano , Estudios de Casos y Controles , Femenino , Humanos , Imagenología Tridimensional , Obesidad/complicaciones , Tomografía Computarizada por Rayos X/métodos , Adulto JovenRESUMEN
Attempts at causing ventromedial hyperphagia in ruminants have been hitherto unsuccessful. In our experiments perfusion of the ventriculocisternal system with pentobarbital caused marked hyperphagia. This suggests that the ventromedial hypothalamic area is functioning in ruminants, probably as in monogastric animals, by inhibiting the lateral area.
Asunto(s)
Apetito , Conducta Animal , Encéfalo/efectos de los fármacos , Cabras/efectos de los fármacos , Pentobarbital/farmacología , Animales , PerfusiónRESUMEN
Cholecystokinin octapeptide decreased food intake in a dose-related manner when injected continuously into the lateral cerebral ventricles of sheep that had been deprived of food for 2, 4, 8, or 24 hours. In sheep deprived of food for 2 hours, as little as 0.01 picomole per minute suppressed feeding 35 percent 1 hour after beginning injection. Pentagastrin also decreased feeding in the 2-hour group, but only at a much higher dose range. Secretin had no effect. These findings support the hypothesis that cholecystokinin octapeptide acts on central nervous system structures that are involved in control of food intake.
Asunto(s)
Colecistoquinina/farmacología , Conducta Alimentaria/efectos de los fármacos , Animales , Encéfalo/efectos de los fármacos , Colecistoquinina/administración & dosificación , Depresión Química , Inyecciones Intraventriculares , Pentagastrina/farmacología , Fragmentos de Péptidos/farmacología , Ratas , Secretina/farmacología , Ovinos , Especificidad de la EspecieRESUMEN
The role of brain cholecystokinin peptides in satiety was further assessed by using antibody to cholecystokinin to reduce cholecystokinin activity in the cerebrospinal fluid of sheep. Food intakes were increased approximately 100 percent during the 2-hour continuous injection of antibody into the cerebrospinal fluid. This supports the hypothesis that, during feeding, cholecystokinin is released into the cerebrospinal fluid, which transports it to the receptors that elicit satiety.
Asunto(s)
Colecistoquinina/fisiología , Conducta Alimentaria/fisiología , Saciedad/fisiología , Animales , Anticuerpos/administración & dosificación , Reacciones Antígeno-Anticuerpo , Castración , Colecistoquinina/líquido cefalorraquídeo , Colecistoquinina/inmunología , Inyecciones Intraventriculares , Masculino , OvinosRESUMEN
Administration of cholecystokinin was recently found to attenuate opiate analgesia. In the present study, the role of endogenous cholecystokinin in opiate analgesia was examined. Endogenously released cholecystokinin was sequestered by antibodies to cholecystokinin developed in response to an active immunization procedure. Morphine analgesia was potentiated and prolonged in rats immunized against cholecystokinin. The rate of development of morphine tolerance, however, was not affected by the antibodies. Endogenous cholecystokinin appears to function as a short-term modulator of opiate action.
Asunto(s)
Colecistoquinina/fisiología , Tolerancia a Medicamentos , Morfina/farmacología , Dolor/fisiología , Animales , Anticuerpos , Colecistoquinina/inmunología , Inmunización , Masculino , Ratas , Ratas Endogámicas , Factores de TiempoRESUMEN
The regulation of bone metabolism mediated by leptin is a complex process that is not clearly understood. Recent studies suggest that CART (cocaine-amphetamine related transcript) is a significant neuronal co-factor when combined with leptin. CART deficiency is thought to result in low trabecular bone mass, but since leptin exerts contrasting effects on trabecular and cortical bone it is possible that cortical bone may not respond to the absence of CART signaling in the same manner as trabecular bone. We tested the hypothesis that CART deficiency decreases cortical bone mass, density, and strength by examining femora of adult wild-type mice (CART(+/+)) and CART-deficient mice (CART(-/-)). DEXA densitometry (PIXImus system) was used to measure whole-bone mineral content (BMC) and mineral density (BMD) from right femora, and pQCT used to calculate densitometric and geometric parameters from the femur midshaft. Femora were also tested in three-point bending, and sections of the tibia analyzed histologically to determine bone marrow adipocyte density (N.At./M.Ar) and endocortical osteoclast number (N.Oc/B.Pm). The control mice weighed less than the mice lacking CART (P<0.001), but mechanical testing data showed no differences (p>0.05) in ultimate force, energy to fracture, stiffness, or intrinsic properties such as ultimate stress, ultimate strain, or modulus. CART-deficient mice did not differ from normal controls in whole-femur BMC (p=0.09), BMD (p=0.19), midshaft cortical bone thickness (p=0.67), midshaft cortical bone area (p=0.59) or N.Oc/B.Pm (p=0.94), although CART deficiency was associated with a three-fold increase in bone marrow adipocyte density (p<0.001). Our data suggest that while the central, neuroendocrine regulation of bone mass via CART signaling may have effects on trabecular mass, absence of CART expression does not significantly alter cortical bone geometry, density, or strength.
Asunto(s)
Peso Corporal , Huesos/fisiopatología , Proteínas del Tejido Nervioso/deficiencia , Resistencia a la Tracción , Absorciometría de Fotón , Adipocitos/patología , Animales , Densidad Ósea , Médula Ósea/patología , Recuento de Células , Fémur/patología , Masculino , Ratones , Ratones Endogámicos C57BL , Ratones NoqueadosRESUMEN
During two studies, effects of recombinant bovine somatotropin (rbST) on plasma and milk IGF's in cows adapted to summer (S; 12 cows) or winter (W; 12 cows) conditions were evaluated. Each study consisted of on-farm periods (30 days) followed by climatology chamber periods (CC; 30 days). Cows were given daily injections of rbST, Sometribove, USAN (25mg/day; 6 cows each study) or saline (control; 6 cows each study). During on-farm periods, blood and milk (am and pm) samples were collected once weekly. During CC periods, blood samples were collected every 2 days and milk samples (am and pm) were collected daily. Plasma IGF-I and IGF-II were increased in cows treated with rbST. A pronounced seasonal pattern in basal and rbST-stimulated plasma IGF-I but not IGF-II was detected. Higher basal and rbST-stimulated plasma IGF-I concentrations in S occurred despite large decreases in feed intake and energy balance. Milk IGF-I and IGF-II was not affected by rbST treatment or season. Although milk IGF-I and IGF-II concentrations were unaffected by rbST treatment, total IGF-output increased due to increased milk yield. The observed seasonal patterns in plasma IGF-I may be indicative of seasonal differences in the coupling of the somatotropin-IGF axis. In particular, we failed to detect an uncoupling of the somatotropin-IGF-I axis in S despite an induced negative energy balance during thermal stress.
Asunto(s)
Bovinos/metabolismo , Hormona del Crecimiento/farmacología , Factor II del Crecimiento Similar a la Insulina/metabolismo , Factor I del Crecimiento Similar a la Insulina/metabolismo , Leche/metabolismo , Estaciones del Año , Animales , Industria Lechera , Metabolismo Energético/efectos de los fármacos , Femenino , Lactancia/sangre , Lactancia/efectos de los fármacos , Lactancia/metabolismo , Leche/efectos de los fármacos , Fotoperiodo , Plasma/efectos de los fármacos , Plasma/metabolismo , Proteínas Recombinantes/farmacología , Estrés Fisiológico/metabolismo , TemperaturaRESUMEN
In our previous report, intracerebroventricular (i.c.v.) administration of leptin caused fat depletion by an induced adipocyte apoptosis in addition to influencing lipid metabolism. To uncover the biochemical mechanisms that mediate this response, the present study was designed to determine whether CCAAT/enhancer binding proteins (C/EBP)alpha, -beta and -delta play a role in the leptin-induced fat depletion. Expressions of C/EBPalpha, -beta and -delta in epididymal fat tissues were examined by Western immunoblot and in situ immunocytochemical analysis after 5 days of i.c.v. treatment. Young and old rats (3 and 8 months old) were treated with or without 5 micrograms/day leptin. The expression of C/EBPalpha, -beta and -delta was decreased by i.c.v. leptin treatment in young rats as compared with controls (P<0.05). However, leptin did not influence the expression of C/EBPalpha, -beta and -delta in adipose tissues of 8-month-old rats. The basal level of expression of C/EBPbeta was greater in 8-month-old rats than in 3-month-old rats, (P<0.05) whereas the basal expression of C/EBPalpha and -delta was not different between age groups. These results were confirmed by in situ immunocytochemical analysis. The present study suggests that leptin-induced down-regulation of C/EBPalpha, -beta and -delta might influence adipocyte differentiation and growth in a number of ways.
Asunto(s)
Tejido Adiposo/metabolismo , Ventrículos Cerebrales/fisiología , Proteínas de Unión al ADN/genética , Proteínas Nucleares/genética , Proteínas/farmacología , Tejido Adiposo/efectos de los fármacos , Tejido Adiposo/crecimiento & desarrollo , Envejecimiento , Animales , Peso Corporal/efectos de los fármacos , Proteínas Potenciadoras de Unión a CCAAT , Ventrículos Cerebrales/efectos de los fármacos , Proteínas de Unión al ADN/biosíntesis , Ingestión de Energía/efectos de los fármacos , Elementos de Facilitación Genéticos , Epidídimo , Escherichia coli , Regulación del Desarrollo de la Expresión Génica/efectos de los fármacos , Inmunohistoquímica , Inyecciones Intraventriculares , Leptina , Masculino , Proteínas Nucleares/biosíntesis , Proteínas/administración & dosificación , Ratas , Ratas Sprague-Dawley , Proteínas Recombinantes/administración & dosificación , Proteínas Recombinantes/farmacologíaRESUMEN
Obesity and osteoporosis have grave consequences for human health, quality of life, and even the efficiency of the labor force and economy. However, these pathologies share a common cell progenitor, revealing a surprising target for drug research and development. Recent findings show that high adipocyte count in bone marrow is directly related to bone loss, as fat cells replace osteoblasts (or bone-forming cells). The objective of this review is to examine the importance of adipocyte apoptosis in the treatment of obesity and/or osteoporosis, with special emphasis on natural products as promising leads for drug development. We have induced in vivo adipocyte apoptosis, using leptin, ciliary neurotrophic factor (CNTF), beta adrenergic agonists and conjugated linoleic acid (CLA) in rodents. The results of leptin treatments on rats are suppressed food intake, reduced body weight, reduced body fat, adipocyte apoptosis, and elevated energy expenditure. Further, leptin treatment of leptin-deficient (ob/ob) mice increases endosteal bone formation and bone mineral density. Adipocyte apoptosis has also been induced in vitro using tumor necrosis factor-alpha (TNF-alpha), (-)-epigallocatechin gallate (EGCG) from Camellia sinensis and ajoene, from Allium sativum. Natural products have potential for inducing apoptosis of adipose tissue, inhibiting bone marrow adipogenesis and increasing the expression of osteogenic factors in bone, thereby yielding effective treatments for obesity and osteoporosis.
Asunto(s)
Adipocitos/efectos de los fármacos , Fármacos Antiobesidad/uso terapéutico , Apoptosis/efectos de los fármacos , Obesidad/tratamiento farmacológico , Osteoporosis/tratamiento farmacológico , Adipocitos/metabolismo , Agonistas Adrenérgicos beta/farmacología , Animales , Fármacos Antiobesidad/farmacología , Médula Ósea/metabolismo , Catequina/análogos & derivados , Catequina/farmacología , Diferenciación Celular , Factor Neurotrófico Ciliar/farmacología , Disulfuros/farmacología , Flavonoides/química , Flavonoides/farmacología , Humanos , Leptina/metabolismo , Ácido Linoleico/farmacología , Células Madre Mesenquimatosas/citología , Obesidad/metabolismo , Osteoporosis/metabolismo , Extractos Vegetales/farmacología , Sulfóxidos , Factor de Necrosis Tumoral alfa/farmacologíaRESUMEN
Expression of a Moloney murine leukemia virus (MLV) rat somatotropin fusion gene was examined in a transgenic pig. The fusion gene was integrated in a single site within the genome in a tandem array with approximately eight copies per cell. The integrated in a single site within the genome in a tandem array with approximately eight copies per cell. The integrated MLV-rat somatotropin fusion gene produced high levels of circulating rat somatotropin and resulted in an elevation in the circulating levels of insulin-like growth factor I. Although there was no increase in the rate of growth of the transgenic animal during the rapid growth phase, several phenotypic changes were evident. Skeletal growth was markedly increased and fat deposition was reduced throughout the animal. Blood glucose levels were elevated without ketosis. Northern blot analyses of rat somatotropin RNA revealed that expression of the fusion gene was highest in the spleen, lung, intestine, lymph nodes, and bone marrow. These results show that the MLV promoter can be used to express high levels of biologically active rat somatotropin in transgenic swine.
Asunto(s)
Hormona del Crecimiento/genética , Virus de la Leucemia Murina de Moloney/genética , Animales , Animales Modificados Genéticamente , PorcinosRESUMEN
Ponies are large nonruminant herbivores which are capable of utilizing the products of both enzymatic digestion in the small intestine and bacterial fermentation (volatile fatty acids, VFAs) in the cecum and large colon as sources of metabolizable energy. Recent studies have demonstrated that ponies utilize nutrient stimuli from both carbohydrate and fat digestion in the small intestine and VFAs in the cecum and large colon in the control of meal frequency. These animals, however, rely primarily upon oropharyngeal and external stimuli to control the size and duration of meals. This is perhaps an adaptation to a feeding pattern of small frequent meals and food sources which provide significant amounts of nutrients to the animal system only after microbial fermentation in the hind gut. Nutrient cues which are operant in controlling feed intake in omnivores, carnivores, and ruminants appear to be important primarily in the regulation of meal frequency and long-term energy balance in the equine animal. The emphasis on oropharyngeal stimuli in the immediate control of feed intake of ponies reflects the unusual digestive physiology of these animals relative to other species studied to date.
Asunto(s)
Fenómenos Fisiológicos del Sistema Digestivo , Ingestión de Alimentos , Caballos/fisiología , Animales , Glucemia/metabolismo , Carbohidratos de la Dieta/metabolismo , Grasas de la Dieta/metabolismo , Ingestión de Energía , Metabolismo Energético , Conducta Alimentaria/fisiología , Motilidad Gastrointestinal , Insulina/sangre , Intestino Grueso/fisiología , Saciedad/fisiología , Gusto/fisiologíaRESUMEN
Leptin, produced in adipocytes, works through the central nervous system (CNS) to modulate food intake and energy expenditure, resulting in rapid loss of body fat depots. It is now shown that this process includes adipocyte apoptosis. Adipocyte deletion by apoptosis occurred after intracerebroventricular (i.c.v.) administration of leptin in rats. Adipose tissue of leptin-treated rats demonstrated characteristic features of apoptosis, including internucleosomal fragmentation of genomic DNA, elevated levels of DNA strand breaks and a reduction in total DNA content and cellular volume. These apoptotic features were absent in control and pair-fed rats and in other tissues of leptin-treated rats.
Asunto(s)
Adipocitos/efectos de los fármacos , Apoptosis/efectos de los fármacos , Encéfalo/fisiología , Proteínas/farmacología , Tejido Adiposo/citología , Tejido Adiposo/efectos de los fármacos , Tejido Adiposo/metabolismo , Envejecimiento/fisiología , Animales , Recuento de Células/efectos de los fármacos , ADN/efectos de los fármacos , ADN/metabolismo , Daño del ADN , Fragmentación del ADN , Femenino , Inyecciones Intraventriculares , Leptina , Masculino , Nucleosomas/metabolismo , Ratas , Ratas Sprague-DawleyRESUMEN
Marijuana, long used for the euphoria which results, recently has been found to stimulate hunger in humans but in several laboratory animals cannabinoids decrease food intake. Sheep, relatively more sensitive to chemicals that affect food intake, were injected IV with the d-and l-isomers of tetrahydrocannabinol and with a 9-aza-cannabinol) 9-AC) (8-(1,2-dimethylheptyl)-5,5-dimethyl-5H-[1]benzopyranol[3,4]pyridin-10-01, HCL) and feeding behavior was monitored. In the first 30 min, food intake was increased by the l-isomer and by 9-AC but not affected by d-delta 9-THC. After 24 h, feed intake was decreased by at least one dose of d-and l-delta 9-THC and 9-AC. The l-but not d-isomer was active at very low doses compared with doses used in many laboratory animals.
Asunto(s)
Cannabinoides/farmacología , Conducta Alimentaria/efectos de los fármacos , Animales , Compuestos Aza/farmacología , Conducta de Ingestión de Líquido/efectos de los fármacos , Dronabinol/farmacología , OvinosRESUMEN
There is still much to learn of the sites and mechanisms of action of brain CCK peptides and their interaction with other brain peptides and neurotransmitters. The findings obtained from studies in sheep and other species provide evidence for brain CCK peptides functioning as important transmitters of hunger and satiety signals. We have hypothesized that signals, either neural or humoral, peripherally generated as a result of feeding induce secretion of CCK from specific (paraventricular) brain sites into the CSF (FIG. 1). Specialized ependymal cells, such as tanycytes, may take up CCK from the CSF for transport to receptor sites which mediate CCK's specific functions (such as changes in rumen motility, suppression of insulin secretion, and behavioral satiety). Evidence also exists to indicate the involvement of specific hypothalamic sites in either the release or the action of CCK.
Asunto(s)
Encéfalo/fisiología , Colecistoquinina/fisiología , Saciedad/fisiología , Animales , Encéfalo/efectos de los fármacos , Química Encefálica , Ventrículos Cerebrales/fisiología , Colecistoquinina/análisis , Colecistoquinina/inmunología , Conducta Alimentaria/efectos de los fármacos , Humanos , Sueros Inmunes/inmunología , Ratas , Receptores de Superficie Celular/fisiología , Receptores de Colecistoquinina , Ovinos , Relación Estructura-ActividadRESUMEN
Cholecystokinin octapeptide (CCK-OP) is a potent and specific suppressor of feeding when administered as a continuous lateral cerebral ventricular injection in fasted sheep, and we have proposed that endogenous CCK-OP in the brain is released during meals and acts to terminate feeding. In previous studies, however, only relatively short-term effects of CCK-OP on feeding were examined. In the first experiment of the present series sheep were adapted to a 6-hr feeding period per day. CCK-OP injected continuously for 6 hr into the lateral ventricles reduced feeding during the entire feeding period (809 +/- 72 g, sham; 695 +/- 71 g, carrier; 505 +/- 69 g, CCK-OP; p less than 0.05). In addition mean feed intake for the two days (injection + first post injection day) was significantly reduced by CCK-OP; thus with CCK-OP, sheep did not compensate by the day after injection for the decreased feed intake on injection day. In a second experiment CCK-OP was injected into the lateral ventricles only during four consecutive 15 min meals 2 hours apart. With a dose of 0.159 pmoles/min CCK-OP, size of the second meal was reduced, but with 0.638 pmoles/min CCK-OP feeding during each of the first two meals was reduced and cumulative intake for the four meals was decreased. These results indicate that CCK-OP administered centrally can have long-term effects on feeding, and under appropriate conditions, could result in negative energy balance.
Asunto(s)
Depresores del Apetito , Apetito/efectos de los fármacos , Colecistoquinina/análogos & derivados , Conducta Alimentaria/efectos de los fármacos , Animales , Castración , Colecistoquinina/administración & dosificación , Colecistoquinina/líquido cefalorraquídeo , Colecistoquinina/farmacología , Ingestión de Energía , Inyecciones Intraventriculares , Cinética , Masculino , Ovinos , SincalidaRESUMEN
Brain cholecystokinin (CCK) peptides have been proposed to be involved in the control of feed intake. We have examined the importance of the cerebral ventricular system in CCK-mediated satiety in sheep. Continuous injection of 0.64 pmol/min CCK-8 into the lateral ventricles (LV) decreased feeding, whereas injection of neither 0.64 nor 2.55 pmol/min CCK-8 into the cisterna magna (CM) significantly affected feeding. Thus, it is likely that the rostral, but not caudal, ventricular compartments and/or adjacent brain areas are involved in CCK-8 mediated satiety. The rate of injection of carrier solution (synthetic cerebrospinal fluid [CSF]) was found to affect feed intake during a continuous 75 min injection: feed intakes were greater during injection of sCSF at 0.10 ml/min than during either 0.03 ml/min sCSF or no injection (sham). Injection of 0.64 pmol/min CCK-8 in either 0.03 or 0.10 ml/min decreased feeding. The increased feeding during 0.10 ml/min sCSF injection may have been due to dilution of endogenous CCK released into CSF during the meal. To determine the percent recovery from CSF of exogenous CCK-8, CSF samples from CM were collected during 3 hr continuous LV injections of CCK-8 and inulin (for measurement of bulk absorption). Only 20 to 40 percent of administered CCK-8 was recovered in CM CSF. The loss of CCK-8 was probably not due to degradation in the CSF by proteolytic enzymes, since CCK-8 concentrations did not decrease during in vitro incubation at 37 degrees C for up to 24 hr. We propose that CCK-8 is released during feeding into the ventricular system, and subsequently taken up from CSF by specialized ependymal cells for transport to sites of action.
Asunto(s)
Ventrículos Cerebrales/metabolismo , Colecistoquinina/metabolismo , Saciedad/fisiología , Animales , Colecistoquinina/administración & dosificación , Conducta Alimentaria/fisiología , Inyecciones Intraventriculares , Masculino , Ovinos , Factores de TiempoRESUMEN
Cholecystokinin (CCK), a hormone affecting several gastrointestinal functions, has also been shown to elicit satiety and affect daily meal patterns. Since Zucker obese rats are less sensitive to the satiety effects of CCK, two experiments were designed to determine if they are also less sensitive to the gastric emptying and intestinal transit rate effects of CCK. In the first experiment phenol red was administered to 5.5 hr fasted rats 15 minutes after intraperitoneal injection of CCK-8 or saline. Rats were sacrificed after 30 minutes, the stomach and small intestine were removed, and phenol red content was measured. More phenol red was in the stomach of obese but not lean rats treated with CCK-8. The rate of transit of the contents of the small intestine was increased by CCK-8 and the percent of phenol red in the fourth quarter of the small intestine was greater in obese than lean rats (91 vs 37%, p less than 0.05). In the second experiment gastrointestinal transit of ferric oxide was measured during the light and dark phases of the diurnal cycle, and when obese rats were ad lib or yoke-fed to lean pair-mates. Total gastrointestinal transit time of the ferric oxide was decreased 15% when CCK-8 was administered to yoke-fed obese rats in either the light or dark portions of the diurnal cycle but was not affected in ad lib-fed obese rats or lean rats. Thus, while Zucker obese rats are less sensitive to satiety effects of CCK, they appear to be more sensitive to the gastrointestinal effects of CCK, and therefore it is not clear what role these gastrointestinal responses have on the feeding behavior responses.
Asunto(s)
Colecistoquinina/farmacología , Motilidad Gastrointestinal/efectos de los fármacos , Obesidad/fisiopatología , Fragmentos de Péptidos/farmacología , Animales , Compuestos Férricos/metabolismo , Vaciamiento Gástrico/efectos de los fármacos , Cinética , Fenolsulfonftaleína , Ratas , Ratas Zucker , SincalidaRESUMEN
Cholecystokinin (CCK) and met-enkephalin (MEK) related peptides have been shown to alter feeding behavior subsequent to their injection into the peripheral circulation or directly into the brains of several species. To evaluate the potential role of endogenous brain pools of these peptides in feeding, groups of sheep were sacrificed either immediately following a meal (satiated) or after various intervals of food deprivation (hungry). Content of CCK-gastrin immunoreactivity in the anterior hypothalami of satiated sheep was elevated compared to 2, 4, or 24 hours of food deprivation. Content of MEK increased progressively with longer intervals of fasting (4 and 24 hours) in the amygdala and basomedial hypothalamus, whereas olfactory bulb content decreased with a similar time course. The results support a potential role for anterior hypothalamic CCK/gastrin in behaviors of satiety, whereas MEK neurons of limbic/rhinencephalic regions appear to form part of a separate circuit gradually activated by increasing hunger. Results are discussed in terms of potential target regions of the peptides, as well as the regional levels and feeding response of sheep as compared to available data from other species.
Asunto(s)
Química Encefálica , Colecistoquinina/análisis , Encefalina Metionina/análisis , Gastrinas/análisis , Hambre/fisiología , Saciedad/fisiología , Amígdala del Cerebelo/análisis , Animales , Hipotálamo/análisis , Masculino , Bulbo Olfatorio/análisis , Radioinmunoensayo , OvinosRESUMEN
Rats and golden hamsters show a differential feeding response to intracranial injections of cholecystokinin (CCK). Rats, but not hamsters reduce food intake after CCK injections into the hypothalamic paraventricular nucleus. In view of this species difference, we undertook an immunohistochemical study of the distribution of CCK-immunoreactivity in the hamster hypothalamus and remaining forebrain. CCK-immunoreactive perikarya were abundant in the neocortex, claustrum, hippocampal formation, amygdaloid complex, bed nucleus of the stria terminalis, nucleus of the lateral olfactory tract and in the magnocellular basal nucleus. CCK-immunoreactive neurons had a more restricted distribution in the diencephalon and were relatively rare in the preoptic area-hypothalamus. The only exception was the suprachiasmatic nucleus and adjacent medial anterior hypothalamus, in which CCK-immunoreactive neurons were numerous. CCK-containing perikarya were not observed in the hamster hypothalamic paraventricular and supraoptic nuclei, where they have been reported to occur in the rat. Groups of CCK-positive perikarya were also noted in the hamster thalamic paratenial and parafascicular nuclei. CCK-immunoreactive fibers/terminals were localized in the caudate and putamen, periventricular zones, dorsolateral geniculate, thalamic reticular nucleus and the superficial layer of the optic tectum. Fiber/terminal labeling was also present in those regions associated with CCK-immunoreactive perikarya. Our results indicate that the telencephalic distribution of CCK-containing neurons in the hamster appears to be similar to that reported in the rat. However, several differences occur in the diencephalon. Perhaps the most striking is that the hamster differs from the rat in having a large group of CCK-containing neurons in the suprachiasmatic nucleus, and in lacking the CCK-containing perikarya observed in the rat paraventricular and supraoptic nuclei. These differences may underly species differences in feeding responses to intracranial CCK injections and gonadal responses to short photoperiods. Our data further suggest that the distribution of neuropeptides and other neuroactive substances may not always be conserved during evolution.
Asunto(s)
Encéfalo/metabolismo , Colecistoquinina/metabolismo , Animales , Cricetinae , Femenino , Histocitoquímica , Inmunoquímica , Masculino , Mesocricetus , Ratas , Ratas Endogámicas , Distribución TisularRESUMEN
The distribution of cholecystokinin (CCK)-, Met-enkephalin (M-ENK)- and dynorphin (DYN)-like immunoreactive perikarya were examined in the sheep hypothalamus using the peroxidase-anti-peroxidase technique. CCK- and DYN-containing neurons were found primarily in the suprachiasmatic nucleus (SCH) and supraoptic nucleus (SO). No CCK- or DYN-containing neurons were found in the paraventricular nucleus (PVN). M-ENK-containing neurons were found mainly in the PVN of the hypothalamus. In addition, M-ENK neurons were found in the dorsomedial (DMH), lateral (LH), anterior (AH) and periventricular hypothalamic areas. The distribution of these neuropeptides may provide a basis for understanding differences in responsiveness to centrally administered peptides.